Your browser doesn't support javascript.
loading
NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy.
van den Heuvel, Michel M; Verheij, Marcel; Boshuizen, Rogier; Belderbos, José; Dingemans, Anne-Marie C; De Ruysscher, Dirk; Laurent, Julien; Tighe, Robert; Haanen, John; Quaratino, Sonia.
Afiliación
  • van den Heuvel MM; Department of Medical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121 1066 CX, Amsterdam, The Netherlands. m.vd.heuvel@nki.nl.
  • Verheij M; Department of Radiation Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, The Netherlands. m.verheij@nki.nl.
  • Boshuizen R; Department of Medical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121 1066 CX, Amsterdam, The Netherlands. r.boshuizen@nki.nl.
  • Belderbos J; Department of Radiation Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, The Netherlands. j.belderbos@nki.nl.
  • Dingemans AM; Department of Pulmonology and GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. a.dingemans@mumc.nl.
  • De Ruysscher D; Department of Radiation Oncology, Maastro, Maastricht, The Netherlands and University Hospitals Leuven/KU Leuven, Leuven, Belgium. dirk.deruysscher@uzleuven.be.
  • Laurent J; Merck KGaA, Darmstadt, Germany. Julien.Laurent@merckgroup.com.
  • Tighe R; EMD Serono, Billerica, MA, USA subsidiary of Merck KGaA, Darmstadt, Germany. robert.tighe@emdserono.com.
  • Haanen J; Department of Medical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121 1066 CX, Amsterdam, The Netherlands. j.haanen@nki.nl.
  • Quaratino S; Merck KGaA, Darmstadt, Germany. sonia.quaratino@novartis.com.
J Transl Med ; 13: 32, 2015 Jan 27.
Article en En | MEDLINE | ID: mdl-25622640

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Recombinantes de Fusión / Interleucina-2 / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Transl Med Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Recombinantes de Fusión / Interleucina-2 / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Transl Med Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido